Abstract:Amycolatopsis sp. strain TNS106 harbors a ristomycin-biosynthetic gene cluster (asr) in its genome and produces ristomycin A. Deletion of the sole cluster-situated StrR family regulatory gene, asrR, abolished ristomycin A production and the transcription of the asr genes orf5 to orf39. The ristomycin A fermentation titer in Amycolatopsis sp. strain TNS106 was dramatically improved by overexpression of asrR and a heterologous StrR family regulatory gene, bbr, from the balhimycin-biosynthetic gene cluster (BGC) utilizing strong promoters and multiple gene copies. Ristomycin A production was improved by approximately 60-fold, resulting in a fermentation titer of 4.01 g/liter in flask culture, in one of the engineered strains. Overexpression of AsrR and Bbr upregulated transcription of tested asr biosynthetic genes, indicating that these asr genes were positively regulated by AsrR and Bbr. However, only the promoter region of the asrR operon and the intergenic region upstream of orf12 were bound by AsrR and Bbr in gel retardation assays, suggesting that AsrR and Bbr directly regulated the asrR operon and probably orf12 to orf14 but no other asr biosynthetic genes. Further assays with synthetic short probes showed that AsrR and Bbr specifically bound not only probes containing the canonical inverted repeats but also a probe with only one 7-bp element of the inverted repeats in its native context. AsrR and Bbr have an N-terminal ParB-like domain and a central winged helix-turn-helix DNA-binding domain. Site-directed mutations indicated that the N-terminal ParB-like domain was involved in activation of ristomycin A biosynthesis and did not affect the DNA-binding activity of AsrR and Bbr. IMPORTANCE This study showed that overexpression of either a native StrR family regulator (AsrR) or a heterologous StrR family regulator (Bbr) dramatically improved ristomycin A production by increasing the transcription of biosynthetic genes directly or indirectly. The conserved ParB-like domain of AsrR and Bbr was demonstrated to be involved in the regulation of asr BGC expression. These findings provide new insights into the mechanism of StrR family regulators in the regulation of glycopeptide antibiotic biosynthesis. Furthermore, the regulator overexpression plasmids constructed in this study could serve as valuable tools for strain improvement and genome mining for new glycopeptide antibiotics. In addition, ristomycin A is a type III glycopeptide antibiotic clinically used as a diagnostic reagent due to its side effects. The overproduction strains engineered in this study are ideal materials for industrial production of ristomycin A.

Fine-tuning gene expression of regulator AdmX for improved biosynthesis of andrimid in Erwinia persicina BST187

Improved production of andrimid in Erwinia persicina BST187 strain by fermentation optimization

Reverse Biological Engineering Of Hrdb To Enhance The Production Of Avermectins In An Industrial Strain Of Streptomyces Avermitilis

Enhancing Ristomycin A Production by Overexpression of ParB-Like StrR Family Regulators Controlling the Biosynthesis Genes

Improvement of Rimocidin Biosynthesis by Increasing Supply of Precursor Malonyl-CoA via Over-expression of Acetyl-CoA Carboxylase in Streptomyces rimosus M527

Precursor supply for erythromycin biosynthesis: engineering of propionate assimilation pathway based on propionylation modification.

Comparative Expression Profiling of Genes Involved in Primary Metabolism in High-Yield and Wild-Type Strains of Acremonium Chrysogenum

Dissecting and engineering of the TetR family regulator SACE_7301 for enhanced erythromycin production in Saccharopolyspora erythraea

Biosensor-assisted Transcriptional Regulator Engineering for Methylobacterium Extorquens AM1 to Improve Mevalonate Synthesis by Increasing the Acetyl-Coa Supply.

Directed evolution of the nonribosomal peptide synthetase AdmK generates new andrimid derivatives in vivo

Enhancement of acyl‐CoA precursor supply for increased avermectin B1a production by engineering meilingmycin polyketide synthase and key primary metabolic pathway genes

Engineering of primary metabolic pathways for titer improvement of milbemycins in Streptomyces bingchenggensis

De novo biosynthesis of α‐aminoadipate via multi‐strategy metabolic engineering in Escherichia coli

Metabolic Engineering Strategies Based on Secondary Messengers (p)ppgpp and C-di-GMP to Increase Erythromycin Yield in Saccharopolyspora Erythraea.

Enhancement of edeine production in Brevibacillus brevis X23 via in situ promoter engineering

Inactivation of SACE_3446, a TetR Family Transcriptional Regulator, Stimulates Erythromycin Production in Saccharopolyspora Erythraea

Genetic Modulation of the Overexpression of Tailoring Genes Eryk and Eryg Leading to the Improvement of Erythromycin A Purity and Production in Saccharopolyspora Erythraea Fermentation

Transposon-based Identification of a Negative Regulator for the Antibiotic Hyper-Production in Streptomyces

Enhancement of Bleomycin Production in Streptomyces Verticillus Through Global Metabolic Regulation of N -Acetylglucosamine and Assisted Metabolic Profiling Analysis

Enhancing erythromycin production in Saccharopolyspora erythraea through rational engineering and fermentation refinement: A Design‐Build‐Test‐Learn approach

Comparative Genomic and Transcriptomic Analysis Guides to Further Enhance the Biosynthesis of Erythromycin by an Overproducer